nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—Amitriptyline—migraine	0.364	1	CrCtD
Cyclobenzaprine—HTR2A—migraine	0.152	1	CbGaD
Cyclobenzaprine—HTR2A—Amitriptyline—migraine	0.0277	0.202	CbGbCtD
Cyclobenzaprine—Olopatadine—Amitriptyline—migraine	0.0269	0.106	CrCrCtD
Cyclobenzaprine—Indecainide—Amitriptyline—migraine	0.0206	0.081	CrCrCtD
Cyclobenzaprine—Cyproheptadine—Amitriptyline—migraine	0.0168	0.0662	CrCrCtD
Cyclobenzaprine—Indecainide—Propranolol—migraine	0.016	0.063	CrCrCtD
Cyclobenzaprine—Nortriptyline—Amitriptyline—migraine	0.0143	0.0564	CrCrCtD
Cyclobenzaprine—Doxepin—Amitriptyline—migraine	0.0129	0.0509	CrCrCtD
Cyclobenzaprine—CYP1A2—Propranolol—migraine	0.0129	0.0941	CbGbCtD
Cyclobenzaprine—CYP2D6—Timolol—migraine	0.012	0.087	CbGbCtD
Cyclobenzaprine—Phenindione—Amitriptyline—migraine	0.0118	0.0465	CrCrCtD
Cyclobenzaprine—Dimetindene—Amitriptyline—migraine	0.0118	0.0465	CrCrCtD
Cyclobenzaprine—Doxylamine—Amitriptyline—migraine	0.0112	0.044	CrCrCtD
Cyclobenzaprine—CYP1A2—Amitriptyline—migraine	0.0112	0.0814	CbGbCtD
Cyclobenzaprine—CYP2D6—Propranolol—migraine	0.0107	0.0775	CbGbCtD
Cyclobenzaprine—CYP1A2—Valproic Acid—migraine	0.0102	0.0742	CbGbCtD
Cyclobenzaprine—Tripelennamine—Amitriptyline—migraine	0.0101	0.0398	CrCrCtD
Cyclobenzaprine—Trimipramine—Amitriptyline—migraine	0.00989	0.0389	CrCrCtD
Cyclobenzaprine—Dimetacrine—Amitriptyline—migraine	0.00946	0.0372	CrCrCtD
Cyclobenzaprine—Bromodiphenhydramine—Amitriptyline—migraine	0.00946	0.0372	CrCrCtD
Cyclobenzaprine—Pheniramine—Amitriptyline—migraine	0.00926	0.0364	CrCrCtD
Cyclobenzaprine—CYP2D6—Amitriptyline—migraine	0.00921	0.067	CbGbCtD
Cyclobenzaprine—Imipramine—Amitriptyline—migraine	0.00907	0.0357	CrCrCtD
Cyclobenzaprine—Chlorprothixene—Amitriptyline—migraine	0.00907	0.0357	CrCrCtD
Cyclobenzaprine—CYP1A2—Verapamil—migraine	0.00887	0.0646	CbGbCtD
Cyclobenzaprine—Promethazine—Amitriptyline—migraine	0.00839	0.033	CrCrCtD
Cyclobenzaprine—Alimemazine—Amitriptyline—migraine	0.00824	0.0324	CrCrCtD
Cyclobenzaprine—Clofedanol—Amitriptyline—migraine	0.00768	0.0302	CrCrCtD
Cyclobenzaprine—Orphenadrine—Amitriptyline—migraine	0.00743	0.0292	CrCrCtD
Cyclobenzaprine—CYP2D6—Verapamil—migraine	0.00731	0.0532	CbGbCtD
Cyclobenzaprine—Promazine—Amitriptyline—migraine	0.0071	0.0279	CrCrCtD
Cyclobenzaprine—CYP3A4—Propranolol—migraine	0.00677	0.0493	CbGbCtD
Cyclobenzaprine—Diphenhydramine—Amitriptyline—migraine	0.0066	0.026	CrCrCtD
Cyclobenzaprine—CYP3A4—Amitriptyline—migraine	0.00586	0.0426	CbGbCtD
Cyclobenzaprine—CYP3A4—Valproic Acid—migraine	0.00534	0.0388	CbGbCtD
Cyclobenzaprine—CYP3A4—Topiramate—migraine	0.00482	0.0351	CbGbCtD
Cyclobenzaprine—CYP3A4—Verapamil—migraine	0.00465	0.0338	CbGbCtD
Cyclobenzaprine—HTR2A—trigeminal nucleus—migraine	0.00435	0.312	CbGeAlD
Cyclobenzaprine—HTR2A—locus ceruleus—migraine	0.0014	0.1	CbGeAlD
Cyclobenzaprine—HTR2A—trigeminal nerve—migraine	0.00114	0.0819	CbGeAlD
Cyclobenzaprine—HTR2A—sympathetic nervous system—migraine	0.0011	0.0791	CbGeAlD
Cyclobenzaprine—HTR2A—cranial nerve—migraine	0.000815	0.0584	CbGeAlD
Cyclobenzaprine—HTR2A—pons—migraine	0.000805	0.0577	CbGeAlD
Cyclobenzaprine—HTR2A—autonomic nervous system—migraine	0.000743	0.0532	CbGeAlD
Cyclobenzaprine—HTR2A—Serotonin receptors—HTR1D—migraine	0.000688	0.0799	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin receptors—HTR2B—migraine	0.00064	0.0743	CbGpPWpGaD
Cyclobenzaprine—HTR2A—pineal body—migraine	0.000575	0.0412	CbGeAlD
Cyclobenzaprine—HTR2A—peripheral nervous system—migraine	0.000536	0.0384	CbGeAlD
Cyclobenzaprine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2B—migraine	0.000425	0.0494	CbGpPWpGaD
Cyclobenzaprine—HTR2A—nerve—migraine	0.000418	0.0299	CbGeAlD
Cyclobenzaprine—HTR2A—Serotonin receptors—HTR1B—migraine	0.000417	0.0484	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin receptors—HTR1A—migraine	0.000401	0.0466	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin receptors—HTR2C—migraine	0.000388	0.045	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin receptors—HTR7—migraine	0.00034	0.0394	CbGpPWpGaD
Cyclobenzaprine—HTR2A—blood vessel—migraine	0.000328	0.0235	CbGeAlD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—HTR1D—migraine	0.000306	0.0356	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—HTR2B—migraine	0.000285	0.0331	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2C—migraine	0.000258	0.0299	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR1D—migraine	0.000258	0.0299	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR2B—migraine	0.000239	0.0278	CbGpPWpGaD
Cyclobenzaprine—HTR2A—neck—migraine	0.000235	0.0168	CbGeAlD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—HTR1B—migraine	0.000186	0.0216	CbGpPWpGaD
Cyclobenzaprine—HTR2A—brainstem—migraine	0.000179	0.0128	CbGeAlD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—HTR1A—migraine	0.000179	0.0208	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—HTR2C—migraine	0.000173	0.02	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—brainstem—migraine	0.000163	0.0117	CbGeAlD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR1B—migraine	0.000156	0.0181	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Monoamine GPCRs—HTR7—migraine	0.000151	0.0176	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR1A—migraine	0.00015	0.0174	CbGpPWpGaD
Cyclobenzaprine—HTR2A—cardiovascular system—migraine	0.000146	0.0105	CbGeAlD
Cyclobenzaprine—Cyproheptadine—HTR2B—migraine	0.000145	0.0718	CrCbGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR2C—migraine	0.000145	0.0169	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000128	0.0148	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Amine ligand-binding receptors—HTR7—migraine	0.000127	0.0148	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—HTR3A—migraine	0.000109	0.0126	CbGpPWpGaD
Cyclobenzaprine—Orphenadrine—SCN1A—migraine	0.000105	0.052	CrCbGaD
Cyclobenzaprine—Protriptyline—SLC6A4—migraine	0.000104	0.0514	CrCbGaD
Cyclobenzaprine—Chlorprothixene—HTR2B—migraine	0.0001	0.0495	CrCbGaD
Cyclobenzaprine—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	9.95e-05	0.0115	CbGpPWpGaD
Cyclobenzaprine—HTR2A—head—migraine	9.91e-05	0.0071	CbGeAlD
Cyclobenzaprine—Trimipramine—HTR3A—migraine	9.47e-05	0.0468	CrCbGaD
Cyclobenzaprine—HTR2A—nervous system—migraine	9.39e-05	0.00673	CbGeAlD
Cyclobenzaprine—Trimipramine—HTR1D—migraine	9.37e-05	0.0463	CrCbGaD
Cyclobenzaprine—HTR2A—central nervous system—migraine	9.04e-05	0.00648	CbGeAlD
Cyclobenzaprine—CYP2D6—head—migraine	9.03e-05	0.00647	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellum—migraine	8.84e-05	0.00633	CbGeAlD
Cyclobenzaprine—Doxepin—HTR2B—migraine	8.84e-05	0.0436	CrCbGaD
Cyclobenzaprine—CYP3A4—nervous system—migraine	8.7e-05	0.00623	CbGeAlD
Cyclobenzaprine—CYP2D6—nervous system—migraine	8.56e-05	0.00613	CbGeAlD
Cyclobenzaprine—CYP3A4—central nervous system—migraine	8.37e-05	0.006	CbGeAlD
Cyclobenzaprine—CYP2D6—central nervous system—migraine	8.24e-05	0.0059	CbGeAlD
Cyclobenzaprine—CYP2D6—cerebellum—migraine	8.05e-05	0.00577	CbGeAlD
Cyclobenzaprine—HTR2A—GPCRs, Other—EDNRA—migraine	7.46e-05	0.00866	CbGpPWpGaD
Cyclobenzaprine—HTR2A—brain—migraine	7.18e-05	0.00514	CbGeAlD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—HTR2B—migraine	7.11e-05	0.00826	CbGpPWpGaD
Cyclobenzaprine—Cyproheptadine—HTR2C—migraine	7.11e-05	0.0351	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR1D—migraine	6.91e-05	0.0341	CrCbGaD
Cyclobenzaprine—Cyproheptadine—HTR1A—migraine	6.9e-05	0.0341	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Other—HTR7—migraine	6.72e-05	0.0078	CbGpPWpGaD
Cyclobenzaprine—Abdominal pain—Propranolol—migraine	6.66e-05	0.000978	CcSEcCtD
Cyclobenzaprine—Flatulence—Valproic Acid—migraine	6.64e-05	0.000974	CcSEcCtD
Cyclobenzaprine—Constipation—Verapamil—migraine	6.63e-05	0.000973	CcSEcCtD
Cyclobenzaprine—Tension—Valproic Acid—migraine	6.61e-05	0.00097	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Valproic Acid—migraine	6.6e-05	0.000968	CcSEcCtD
Cyclobenzaprine—Vomiting—Amitriptyline—migraine	6.58e-05	0.000966	CcSEcCtD
Cyclobenzaprine—Nervousness—Valproic Acid—migraine	6.54e-05	0.00096	CcSEcCtD
Cyclobenzaprine—CYP2D6—brain—migraine	6.54e-05	0.00469	CbGeAlD
Cyclobenzaprine—Rash—Amitriptyline—migraine	6.53e-05	0.000958	CcSEcCtD
Cyclobenzaprine—Dermatitis—Amitriptyline—migraine	6.52e-05	0.000957	CcSEcCtD
Cyclobenzaprine—Headache—Amitriptyline—migraine	6.49e-05	0.000952	CcSEcCtD
Cyclobenzaprine—Tinnitus—Timolol—migraine	6.42e-05	0.000943	CcSEcCtD
Cyclobenzaprine—Hepatitis—Gabapentin—migraine	6.41e-05	0.000942	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Topiramate—migraine	6.4e-05	0.00094	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Verapamil—migraine	6.39e-05	0.000938	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Gabapentin—migraine	6.38e-05	0.000937	CcSEcCtD
Cyclobenzaprine—Hallucination—Gabapentin—migraine	6.38e-05	0.000937	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Gabapentin—migraine	6.37e-05	0.000934	CcSEcCtD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	6.36e-05	0.00739	CbGpPWpGaD
Cyclobenzaprine—Vision blurred—Valproic Acid—migraine	6.35e-05	0.000932	CcSEcCtD
Cyclobenzaprine—Tremor—Valproic Acid—migraine	6.31e-05	0.000926	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Topiramate—migraine	6.27e-05	0.00092	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Valproic Acid—migraine	6.25e-05	0.000917	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Topiramate—migraine	6.23e-05	0.000914	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Propranolol—migraine	6.21e-05	0.000911	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Topiramate—migraine	6.21e-05	0.000911	CcSEcCtD
Cyclobenzaprine—Agitation—Valproic Acid—migraine	6.19e-05	0.000909	CcSEcCtD
Cyclobenzaprine—Urticaria—Verapamil—migraine	6.16e-05	0.000904	CcSEcCtD
Cyclobenzaprine—Angioedema—Valproic Acid—migraine	6.15e-05	0.000903	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Timolol—migraine	6.15e-05	0.000903	CcSEcCtD
Cyclobenzaprine—Nausea—Amitriptyline—migraine	6.15e-05	0.000903	CcSEcCtD
Cyclobenzaprine—Weight increased—Topiramate—migraine	6.14e-05	0.000901	CcSEcCtD
Cyclobenzaprine—Alopecia—Timolol—migraine	6.09e-05	0.000893	CcSEcCtD
Cyclobenzaprine—Malaise—Valproic Acid—migraine	6.07e-05	0.000892	CcSEcCtD
Cyclobenzaprine—Vertigo—Valproic Acid—migraine	6.05e-05	0.000888	CcSEcCtD
Cyclobenzaprine—Asthenia—Propranolol—migraine	6.05e-05	0.000888	CcSEcCtD
Cyclobenzaprine—Leukopenia—Valproic Acid—migraine	6.03e-05	0.000885	CcSEcCtD
Cyclobenzaprine—Tinnitus—Gabapentin—migraine	5.98e-05	0.000878	CcSEcCtD
Cyclobenzaprine—Palpitations—Valproic Acid—migraine	5.95e-05	0.000874	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	5.91e-05	0.00687	CbGpPWpGaD
Cyclobenzaprine—Neuropathy peripheral—Topiramate—migraine	5.89e-05	0.000865	CcSEcCtD
Cyclobenzaprine—Tension—Timolol—migraine	5.88e-05	0.000864	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Timolol—migraine	5.87e-05	0.000862	CcSEcCtD
Cyclobenzaprine—Stomatitis—Topiramate—migraine	5.86e-05	0.00086	CcSEcCtD
Cyclobenzaprine—Nervousness—Timolol—migraine	5.82e-05	0.000855	CcSEcCtD
Cyclobenzaprine—Hypertension—Valproic Acid—migraine	5.82e-05	0.000854	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Propranolol—migraine	5.77e-05	0.000846	CcSEcCtD
Cyclobenzaprine—Chest pain—Valproic Acid—migraine	5.73e-05	0.000842	CcSEcCtD
Cyclobenzaprine—Myalgia—Valproic Acid—migraine	5.73e-05	0.000842	CcSEcCtD
Cyclobenzaprine—Anxiety—Valproic Acid—migraine	5.71e-05	0.000839	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Verapamil—migraine	5.71e-05	0.000838	CcSEcCtD
Cyclobenzaprine—Alopecia—Gabapentin—migraine	5.67e-05	0.000832	CcSEcCtD
Cyclobenzaprine—Discomfort—Valproic Acid—migraine	5.67e-05	0.000832	CcSEcCtD
Cyclobenzaprine—Vision blurred—Timolol—migraine	5.65e-05	0.000829	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Topiramate—migraine	5.61e-05	0.000823	CcSEcCtD
Cyclobenzaprine—Dry mouth—Valproic Acid—migraine	5.61e-05	0.000823	CcSEcCtD
Cyclobenzaprine—Dizziness—Propranolol—migraine	5.57e-05	0.000818	CcSEcCtD
Cyclobenzaprine—Asthenia—Verapamil—migraine	5.56e-05	0.000817	CcSEcCtD
Cyclobenzaprine—Confusional state—Valproic Acid—migraine	5.54e-05	0.000814	CcSEcCtD
Cyclobenzaprine—Flatulence—Gabapentin—migraine	5.5e-05	0.000808	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	5.5e-05	0.00639	CbGpPWpGaD
Cyclobenzaprine—Anaphylactic shock—Valproic Acid—migraine	5.5e-05	0.000807	CcSEcCtD
Cyclobenzaprine—Oedema—Valproic Acid—migraine	5.5e-05	0.000807	CcSEcCtD
Cyclobenzaprine—Pruritus—Verapamil—migraine	5.49e-05	0.000805	CcSEcCtD
Cyclobenzaprine—Tension—Gabapentin—migraine	5.48e-05	0.000804	CcSEcCtD
Cyclobenzaprine—Angioedema—Timolol—migraine	5.48e-05	0.000804	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Gabapentin—migraine	5.47e-05	0.000803	CcSEcCtD
Cyclobenzaprine—Nervousness—Gabapentin—migraine	5.42e-05	0.000796	CcSEcCtD
Cyclobenzaprine—Hepatitis—Topiramate—migraine	5.4e-05	0.000792	CcSEcCtD
Cyclobenzaprine—Vertigo—Timolol—migraine	5.39e-05	0.000791	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Valproic Acid—migraine	5.38e-05	0.00079	CcSEcCtD
Cyclobenzaprine—Syncope—Timolol—migraine	5.38e-05	0.000789	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Topiramate—migraine	5.37e-05	0.000788	CcSEcCtD
Cyclobenzaprine—Hallucination—Topiramate—migraine	5.37e-05	0.000788	CcSEcCtD
Cyclobenzaprine—Tachycardia—Valproic Acid—migraine	5.37e-05	0.000788	CcSEcCtD
Cyclobenzaprine—Vomiting—Propranolol—migraine	5.36e-05	0.000787	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Topiramate—migraine	5.36e-05	0.000786	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Valproic Acid—migraine	5.31e-05	0.00078	CcSEcCtD
Cyclobenzaprine—Rash—Propranolol—migraine	5.31e-05	0.00078	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CALCRL—migraine	5.31e-05	0.00617	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—RAMP1—migraine	5.31e-05	0.00617	CbGpPWpGaD
Cyclobenzaprine—Dermatitis—Propranolol—migraine	5.31e-05	0.000779	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Verapamil—migraine	5.31e-05	0.000779	CcSEcCtD
Cyclobenzaprine—Palpitations—Timolol—migraine	5.3e-05	0.000778	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Timolol—migraine	5.27e-05	0.000774	CcSEcCtD
Cyclobenzaprine—Vision blurred—Gabapentin—migraine	5.26e-05	0.000772	CcSEcCtD
Cyclobenzaprine—Anorexia—Valproic Acid—migraine	5.24e-05	0.000769	CcSEcCtD
Cyclobenzaprine—Tremor—Gabapentin—migraine	5.23e-05	0.000768	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Gabapentin—migraine	5.18e-05	0.00076	CcSEcCtD
Cyclobenzaprine—Hypertension—Timolol—migraine	5.18e-05	0.00076	CcSEcCtD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—HTR1A—migraine	5.16e-05	0.00599	CbGpPWpGaD
Cyclobenzaprine—Hypotension—Valproic Acid—migraine	5.14e-05	0.000754	CcSEcCtD
Cyclobenzaprine—Agitation—Gabapentin—migraine	5.13e-05	0.000753	CcSEcCtD
Cyclobenzaprine—Dizziness—Verapamil—migraine	5.13e-05	0.000753	CcSEcCtD
Cyclobenzaprine—Myalgia—Timolol—migraine	5.11e-05	0.000749	CcSEcCtD
Cyclobenzaprine—Chest pain—Timolol—migraine	5.11e-05	0.000749	CcSEcCtD
Cyclobenzaprine—Angioedema—Gabapentin—migraine	5.1e-05	0.000749	CcSEcCtD
Cyclobenzaprine—Anxiety—Timolol—migraine	5.09e-05	0.000747	CcSEcCtD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TAC1—migraine	5.08e-05	0.0059	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	5.07e-05	0.00588	CbGpPWpGaD
Cyclobenzaprine—Discomfort—Timolol—migraine	5.04e-05	0.00074	CcSEcCtD
Cyclobenzaprine—Malaise—Gabapentin—migraine	5.04e-05	0.000739	CcSEcCtD
Cyclobenzaprine—Tinnitus—Topiramate—migraine	5.03e-05	0.000739	CcSEcCtD
Cyclobenzaprine—Vertigo—Gabapentin—migraine	5.02e-05	0.000736	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Valproic Acid—migraine	5.01e-05	0.000735	CcSEcCtD
Cyclobenzaprine—Syncope—Gabapentin—migraine	5.01e-05	0.000735	CcSEcCtD
Cyclobenzaprine—Nausea—Propranolol—migraine	5.01e-05	0.000735	CcSEcCtD
Cyclobenzaprine—Leukopenia—Gabapentin—migraine	5e-05	0.000734	CcSEcCtD
Cyclobenzaprine—Dry mouth—Timolol—migraine	4.99e-05	0.000733	CcSEcCtD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—migraine	4.98e-05	0.00579	CbGpPWpGaD
Cyclobenzaprine—Insomnia—Valproic Acid—migraine	4.97e-05	0.00073	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Valproic Acid—migraine	4.94e-05	0.000725	CcSEcCtD
Cyclobenzaprine—Palpitations—Gabapentin—migraine	4.93e-05	0.000724	CcSEcCtD
Cyclobenzaprine—Confusional state—Timolol—migraine	4.93e-05	0.000724	CcSEcCtD
Cyclobenzaprine—Vomiting—Verapamil—migraine	4.93e-05	0.000724	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Gabapentin—migraine	4.91e-05	0.00072	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—HTR2C—migraine	4.9e-05	0.0242	CrCbGaD
Cyclobenzaprine—Dyspnoea—Valproic Acid—migraine	4.9e-05	0.000719	CcSEcCtD
Cyclobenzaprine—Oedema—Timolol—migraine	4.89e-05	0.000718	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Timolol—migraine	4.89e-05	0.000718	CcSEcCtD
Cyclobenzaprine—Rash—Verapamil—migraine	4.89e-05	0.000718	CcSEcCtD
Cyclobenzaprine—Somnolence—Valproic Acid—migraine	4.89e-05	0.000717	CcSEcCtD
Cyclobenzaprine—Dermatitis—Verapamil—migraine	4.88e-05	0.000717	CcSEcCtD
Cyclobenzaprine—Headache—Verapamil—migraine	4.86e-05	0.000713	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Valproic Acid—migraine	4.84e-05	0.00071	CcSEcCtD
Cyclobenzaprine—Convulsion—Gabapentin—migraine	4.84e-05	0.00071	CcSEcCtD
Cyclobenzaprine—Hypertension—Gabapentin—migraine	4.82e-05	0.000708	CcSEcCtD
Cyclobenzaprine—Shock—Timolol—migraine	4.81e-05	0.000707	CcSEcCtD
Cyclobenzaprine—Nortriptyline—HTR2C—migraine	4.81e-05	0.0238	CrCbGaD
Cyclobenzaprine—Decreased appetite—Valproic Acid—migraine	4.78e-05	0.000701	CcSEcCtD
Cyclobenzaprine—Alopecia—Topiramate—migraine	4.77e-05	0.0007	CcSEcCtD
Cyclobenzaprine—Myalgia—Gabapentin—migraine	4.75e-05	0.000698	CcSEcCtD
Cyclobenzaprine—Chest pain—Gabapentin—migraine	4.75e-05	0.000698	CcSEcCtD
Cyclobenzaprine—Fatigue—Valproic Acid—migraine	4.74e-05	0.000696	CcSEcCtD
Cyclobenzaprine—Anxiety—Gabapentin—migraine	4.74e-05	0.000695	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Timolol—migraine	4.73e-05	0.000694	CcSEcCtD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	4.71e-05	0.00547	CbGpPWpGaD
Cyclobenzaprine—Constipation—Valproic Acid—migraine	4.7e-05	0.00069	CcSEcCtD
Cyclobenzaprine—Discomfort—Gabapentin—migraine	4.7e-05	0.000689	CcSEcCtD
Cyclobenzaprine—Nortriptyline—HTR1A—migraine	4.67e-05	0.0231	CrCbGaD
Cyclobenzaprine—Anorexia—Timolol—migraine	4.66e-05	0.000685	CcSEcCtD
Cyclobenzaprine—Dry mouth—Gabapentin—migraine	4.65e-05	0.000682	CcSEcCtD
Cyclobenzaprine—Flatulence—Topiramate—migraine	4.63e-05	0.000679	CcSEcCtD
Cyclobenzaprine—Tension—Topiramate—migraine	4.61e-05	0.000677	CcSEcCtD
Cyclobenzaprine—Nausea—Verapamil—migraine	4.61e-05	0.000676	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Topiramate—migraine	4.6e-05	0.000675	CcSEcCtD
Cyclobenzaprine—Confusional state—Gabapentin—migraine	4.6e-05	0.000674	CcSEcCtD
Cyclobenzaprine—Hypotension—Timolol—migraine	4.57e-05	0.000671	CcSEcCtD
Cyclobenzaprine—Nervousness—Topiramate—migraine	4.56e-05	0.00067	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Gabapentin—migraine	4.56e-05	0.000669	CcSEcCtD
Cyclobenzaprine—Oedema—Gabapentin—migraine	4.56e-05	0.000669	CcSEcCtD
Cyclobenzaprine—Trimipramine—HTR2C—migraine	4.53e-05	0.0224	CrCbGaD
Cyclobenzaprine—Feeling abnormal—Valproic Acid—migraine	4.53e-05	0.000665	CcSEcCtD
Cyclobenzaprine—Cyproheptadine—HTR2A—migraine	4.53e-05	0.0223	CrCbGaD
Cyclobenzaprine—Gastrointestinal pain—Valproic Acid—migraine	4.5e-05	0.00066	CcSEcCtD
Cyclobenzaprine—Shock—Gabapentin—migraine	4.48e-05	0.000658	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Gabapentin—migraine	4.46e-05	0.000655	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Timolol—migraine	4.46e-05	0.000654	CcSEcCtD
Cyclobenzaprine—Tachycardia—Gabapentin—migraine	4.45e-05	0.000653	CcSEcCtD
Cyclobenzaprine—Vision blurred—Topiramate—migraine	4.43e-05	0.00065	CcSEcCtD
Cyclobenzaprine—Insomnia—Timolol—migraine	4.43e-05	0.00065	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Gabapentin—migraine	4.41e-05	0.000647	CcSEcCtD
Cyclobenzaprine—Tremor—Topiramate—migraine	4.4e-05	0.000646	CcSEcCtD
Cyclobenzaprine—Trimipramine—HTR1A—migraine	4.4e-05	0.0217	CrCbGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—NPS—migraine	4.39e-05	0.0051	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—TAC1—migraine	4.39e-05	0.0051	CbGpPWpGaD
Cyclobenzaprine—Paraesthesia—Timolol—migraine	4.39e-05	0.000645	CcSEcCtD
Cyclobenzaprine—Urticaria—Valproic Acid—migraine	4.37e-05	0.000641	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Timolol—migraine	4.36e-05	0.00064	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Topiramate—migraine	4.36e-05	0.00064	CcSEcCtD
Cyclobenzaprine—Somnolence—Timolol—migraine	4.35e-05	0.000639	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Valproic Acid—migraine	4.35e-05	0.000638	CcSEcCtD
Cyclobenzaprine—Anorexia—Gabapentin—migraine	4.34e-05	0.000638	CcSEcCtD
Cyclobenzaprine—Doxepin—HTR2C—migraine	4.32e-05	0.0213	CrCbGaD
Cyclobenzaprine—Agitation—Topiramate—migraine	4.32e-05	0.000634	CcSEcCtD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—HTR2C—migraine	4.31e-05	0.005	CbGpPWpGaD
Cyclobenzaprine—Dyspepsia—Timolol—migraine	4.31e-05	0.000632	CcSEcCtD
Cyclobenzaprine—Hypotension—Gabapentin—migraine	4.26e-05	0.000625	CcSEcCtD
Cyclobenzaprine—Imipramine—HTR7—migraine	4.26e-05	0.021	CrCbGaD
Cyclobenzaprine—Decreased appetite—Timolol—migraine	4.25e-05	0.000624	CcSEcCtD
Cyclobenzaprine—Tamoxifen—ESR1—migraine	4.24e-05	0.0209	CrCbGaD
Cyclobenzaprine—Malaise—Topiramate—migraine	4.24e-05	0.000622	CcSEcCtD
Cyclobenzaprine—Amitriptyline—HTR7—migraine	4.23e-05	0.0209	CrCbGaD
Cyclobenzaprine—Vertigo—Topiramate—migraine	4.22e-05	0.00062	CcSEcCtD
Cyclobenzaprine—Fatigue—Timolol—migraine	4.22e-05	0.000619	CcSEcCtD
Cyclobenzaprine—Syncope—Topiramate—migraine	4.21e-05	0.000618	CcSEcCtD
Cyclobenzaprine—Leukopenia—Topiramate—migraine	4.21e-05	0.000617	CcSEcCtD
Cyclobenzaprine—Doxepin—HTR1A—migraine	4.19e-05	0.0207	CrCbGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—EDNRA—migraine	4.19e-05	0.00487	CbGpPWpGaD
Cyclobenzaprine—Musculoskeletal discomfort—Gabapentin—migraine	4.15e-05	0.000609	CcSEcCtD
Cyclobenzaprine—Palpitations—Topiramate—migraine	4.15e-05	0.000609	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Topiramate—migraine	4.13e-05	0.000606	CcSEcCtD
Cyclobenzaprine—Insomnia—Gabapentin—migraine	4.12e-05	0.000605	CcSEcCtD
Cyclobenzaprine—Amitriptyline—HTR1B—migraine	4.1e-05	0.0202	CrCbGaD
Cyclobenzaprine—Paraesthesia—Gabapentin—migraine	4.09e-05	0.000601	CcSEcCtD
Cyclobenzaprine—Convulsion—Topiramate—migraine	4.07e-05	0.000597	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Gabapentin—migraine	4.06e-05	0.000596	CcSEcCtD
Cyclobenzaprine—Hypertension—Topiramate—migraine	4.06e-05	0.000595	CcSEcCtD
Cyclobenzaprine—Somnolence—Gabapentin—migraine	4.05e-05	0.000595	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Valproic Acid—migraine	4.05e-05	0.000594	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Timolol—migraine	4.03e-05	0.000592	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Gabapentin—migraine	4.01e-05	0.000589	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Timolol—migraine	4e-05	0.000587	CcSEcCtD
Cyclobenzaprine—Chest pain—Topiramate—migraine	4e-05	0.000587	CcSEcCtD
Cyclobenzaprine—Myalgia—Topiramate—migraine	4e-05	0.000587	CcSEcCtD
Cyclobenzaprine—Nortriptyline—SLC6A4—migraine	3.99e-05	0.0197	CrCbGaD
Cyclobenzaprine—Anxiety—Topiramate—migraine	3.99e-05	0.000585	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Gabapentin—migraine	3.96e-05	0.000581	CcSEcCtD
Cyclobenzaprine—Discomfort—Topiramate—migraine	3.95e-05	0.00058	CcSEcCtD
Cyclobenzaprine—Asthenia—Valproic Acid—migraine	3.94e-05	0.000579	CcSEcCtD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	3.93e-05	0.00456	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	3.93e-05	0.00456	CbGpPWpGaD
Cyclobenzaprine—Fatigue—Gabapentin—migraine	3.93e-05	0.000577	CcSEcCtD
Cyclobenzaprine—Dry mouth—Topiramate—migraine	3.91e-05	0.000574	CcSEcCtD
Cyclobenzaprine—Constipation—Gabapentin—migraine	3.9e-05	0.000572	CcSEcCtD
Cyclobenzaprine—Pruritus—Valproic Acid—migraine	3.89e-05	0.000571	CcSEcCtD
Cyclobenzaprine—Urticaria—Timolol—migraine	3.89e-05	0.000571	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Timolol—migraine	3.87e-05	0.000568	CcSEcCtD
Cyclobenzaprine—Confusional state—Topiramate—migraine	3.87e-05	0.000567	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR1D—migraine	3.86e-05	0.00448	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	3.85e-05	0.00448	CbGpPWpGaD
Cyclobenzaprine—Promazine—HTR2C—migraine	3.84e-05	0.019	CrCbGaD
Cyclobenzaprine—Oedema—Topiramate—migraine	3.83e-05	0.000563	CcSEcCtD
Cyclobenzaprine—Shock—Topiramate—migraine	3.77e-05	0.000554	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Valproic Acid—migraine	3.76e-05	0.000552	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Gabapentin—migraine	3.76e-05	0.000551	CcSEcCtD
Cyclobenzaprine—Trimipramine—SLC6A4—migraine	3.76e-05	0.0185	CrCbGaD
Cyclobenzaprine—Thrombocytopenia—Topiramate—migraine	3.75e-05	0.000551	CcSEcCtD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	3.75e-05	0.00435	CbGpPWpGaD
Cyclobenzaprine—Tachycardia—Topiramate—migraine	3.74e-05	0.000549	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Gabapentin—migraine	3.73e-05	0.000547	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Topiramate—migraine	3.71e-05	0.000544	CcSEcCtD
Cyclobenzaprine—Anorexia—Topiramate—migraine	3.65e-05	0.000536	CcSEcCtD
Cyclobenzaprine—Dizziness—Valproic Acid—migraine	3.64e-05	0.000534	CcSEcCtD
Cyclobenzaprine—Urticaria—Gabapentin—migraine	3.62e-05	0.000531	CcSEcCtD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	3.62e-05	0.0042	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—BDNF—migraine	3.62e-05	0.0042	CbGpPWpGaD
Cyclobenzaprine—Hypersensitivity—Timolol—migraine	3.61e-05	0.000529	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Gabapentin—migraine	3.6e-05	0.000529	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR2B—migraine	3.59e-05	0.00417	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	3.58e-05	0.00416	CbGpPWpGaD
Cyclobenzaprine—Hypotension—Topiramate—migraine	3.58e-05	0.000526	CcSEcCtD
Cyclobenzaprine—Doxepin—SLC6A4—migraine	3.58e-05	0.0177	CrCbGaD
Cyclobenzaprine—Asthenia—Timolol—migraine	3.51e-05	0.000515	CcSEcCtD
Cyclobenzaprine—Vomiting—Valproic Acid—migraine	3.5e-05	0.000513	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Topiramate—migraine	3.49e-05	0.000513	CcSEcCtD
Cyclobenzaprine—Insomnia—Topiramate—migraine	3.47e-05	0.000509	CcSEcCtD
Cyclobenzaprine—Rash—Valproic Acid—migraine	3.47e-05	0.000509	CcSEcCtD
Cyclobenzaprine—Dermatitis—Valproic Acid—migraine	3.46e-05	0.000508	CcSEcCtD
Cyclobenzaprine—Pruritus—Timolol—migraine	3.46e-05	0.000508	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	3.45e-05	0.00401	CbGpPWpGaD
Cyclobenzaprine—Headache—Valproic Acid—migraine	3.44e-05	0.000505	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Topiramate—migraine	3.44e-05	0.000505	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Topiramate—migraine	3.42e-05	0.000502	CcSEcCtD
Cyclobenzaprine—Somnolence—Topiramate—migraine	3.41e-05	0.0005	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Topiramate—migraine	3.38e-05	0.000495	CcSEcCtD
Cyclobenzaprine—Imipramine—HTR2C—migraine	3.36e-05	0.0166	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Gabapentin—migraine	3.36e-05	0.000493	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Timolol—migraine	3.35e-05	0.000491	CcSEcCtD
Cyclobenzaprine—Amitriptyline—HTR2C—migraine	3.34e-05	0.0165	CrCbGaD
Cyclobenzaprine—Decreased appetite—Topiramate—migraine	3.33e-05	0.000489	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	3.33e-05	0.00387	CbGpPWpGaD
Cyclobenzaprine—Fatigue—Topiramate—migraine	3.31e-05	0.000485	CcSEcCtD
Cyclobenzaprine—Constipation—Topiramate—migraine	3.28e-05	0.000481	CcSEcCtD
Cyclobenzaprine—Asthenia—Gabapentin—migraine	3.27e-05	0.00048	CcSEcCtD
Cyclobenzaprine—Nausea—Valproic Acid—migraine	3.27e-05	0.000479	CcSEcCtD
Cyclobenzaprine—Imipramine—HTR1A—migraine	3.26e-05	0.0161	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR1A—migraine	3.24e-05	0.016	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	3.24e-05	0.00376	CbGpPWpGaD
Cyclobenzaprine—Dizziness—Timolol—migraine	3.24e-05	0.000475	CcSEcCtD
Cyclobenzaprine—Pruritus—Gabapentin—migraine	3.22e-05	0.000473	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Topiramate—migraine	3.16e-05	0.000464	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Topiramate—migraine	3.14e-05	0.00046	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—HTR2A—migraine	3.12e-05	0.0154	CrCbGaD
Cyclobenzaprine—Diarrhoea—Gabapentin—migraine	3.12e-05	0.000458	CcSEcCtD
Cyclobenzaprine—Vomiting—Timolol—migraine	3.11e-05	0.000457	CcSEcCtD
Cyclobenzaprine—Rash—Timolol—migraine	3.09e-05	0.000453	CcSEcCtD
Cyclobenzaprine—Dermatitis—Timolol—migraine	3.08e-05	0.000452	CcSEcCtD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	3.07e-05	0.00357	CbGpPWpGaD
Cyclobenzaprine—Headache—Timolol—migraine	3.07e-05	0.00045	CcSEcCtD
Cyclobenzaprine—Nortriptyline—HTR2A—migraine	3.07e-05	0.0151	CrCbGaD
Cyclobenzaprine—Urticaria—Topiramate—migraine	3.05e-05	0.000447	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Topiramate—migraine	3.03e-05	0.000445	CcSEcCtD
Cyclobenzaprine—Dizziness—Gabapentin—migraine	3.01e-05	0.000442	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—RAMP1—migraine	3e-05	0.00349	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CALCRL—migraine	3e-05	0.00349	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	2.96e-05	0.00343	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	2.92e-05	0.00339	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	2.91e-05	0.00338	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	2.91e-05	0.00338	CbGpPWpGaD
Cyclobenzaprine—Nausea—Timolol—migraine	2.91e-05	0.000427	CcSEcCtD
Cyclobenzaprine—Vomiting—Gabapentin—migraine	2.9e-05	0.000425	CcSEcCtD
Cyclobenzaprine—Trimipramine—HTR2A—migraine	2.89e-05	0.0143	CrCbGaD
Cyclobenzaprine—Rash—Gabapentin—migraine	2.87e-05	0.000422	CcSEcCtD
Cyclobenzaprine—Dermatitis—Gabapentin—migraine	2.87e-05	0.000421	CcSEcCtD
Cyclobenzaprine—Headache—Gabapentin—migraine	2.86e-05	0.000419	CcSEcCtD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	2.85e-05	0.00331	CbGpPWpGaD
Cyclobenzaprine—Hypersensitivity—Topiramate—migraine	2.82e-05	0.000415	CcSEcCtD
Cyclobenzaprine—Imipramine—SLC6A4—migraine	2.78e-05	0.0138	CrCbGaD
Cyclobenzaprine—Promethazine—HTR2A—migraine	2.78e-05	0.0137	CrCbGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	2.78e-05	0.00322	CbGpPWpGaD
Cyclobenzaprine—Amitriptyline—SLC6A4—migraine	2.77e-05	0.0137	CrCbGaD
Cyclobenzaprine—Asthenia—Topiramate—migraine	2.75e-05	0.000404	CcSEcCtD
Cyclobenzaprine—Doxepin—HTR2A—migraine	2.75e-05	0.0136	CrCbGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CALCRL—migraine	2.73e-05	0.00316	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—RAMP1—migraine	2.73e-05	0.00316	CbGpPWpGaD
Cyclobenzaprine—Pruritus—Topiramate—migraine	2.71e-05	0.000398	CcSEcCtD
Cyclobenzaprine—Nausea—Gabapentin—migraine	2.71e-05	0.000397	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Topiramate—migraine	2.62e-05	0.000385	CcSEcCtD
Cyclobenzaprine—Dizziness—Topiramate—migraine	2.54e-05	0.000372	CcSEcCtD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	2.5e-05	0.0029	CbGpPWpGaD
Cyclobenzaprine—Promazine—HTR2A—migraine	2.44e-05	0.0121	CrCbGaD
Cyclobenzaprine—Vomiting—Topiramate—migraine	2.44e-05	0.000358	CcSEcCtD
Cyclobenzaprine—Rash—Topiramate—migraine	2.42e-05	0.000355	CcSEcCtD
Cyclobenzaprine—Dermatitis—Topiramate—migraine	2.42e-05	0.000355	CcSEcCtD
Cyclobenzaprine—Headache—Topiramate—migraine	2.4e-05	0.000353	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR1B—migraine	2.34e-05	0.00271	CbGpPWpGaD
Cyclobenzaprine—Nausea—Topiramate—migraine	2.28e-05	0.000334	CcSEcCtD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR1A—migraine	2.25e-05	0.00261	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—NPS—migraine	2.22e-05	0.00257	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—TAC1—migraine	2.22e-05	0.00257	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR1D—migraine	2.18e-05	0.00253	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR2C—migraine	2.17e-05	0.00252	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR2A—migraine	2.14e-05	0.0106	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR2A—migraine	2.13e-05	0.0105	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—EDNRA—migraine	2.11e-05	0.00246	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CALCA—migraine	2.04e-05	0.00236	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR2B—migraine	2.03e-05	0.00235	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR1D—migraine	1.98e-05	0.0023	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR7—migraine	1.9e-05	0.00221	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR2B—migraine	1.84e-05	0.00214	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	1.75e-05	0.00204	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.75e-05	0.00204	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RAMP1—migraine	1.61e-05	0.00187	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CALCRL—migraine	1.61e-05	0.00187	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR1B—migraine	1.32e-05	0.00153	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TNF—migraine	1.31e-05	0.00153	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR1A—migraine	1.27e-05	0.00148	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—NPS—migraine	1.25e-05	0.00145	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—TAC1—migraine	1.25e-05	0.00145	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR2C—migraine	1.23e-05	0.00143	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR1B—migraine	1.2e-05	0.00139	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—EDNRA—migraine	1.19e-05	0.00139	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR1D—migraine	1.17e-05	0.00136	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR1A—migraine	1.15e-05	0.00134	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CALCA—migraine	1.15e-05	0.00134	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—NPS—migraine	1.14e-05	0.00132	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—TAC1—migraine	1.14e-05	0.00132	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR2C—migraine	1.12e-05	0.0013	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR2B—migraine	1.09e-05	0.00126	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EDNRA—migraine	1.08e-05	0.00126	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR7—migraine	1.08e-05	0.00125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CALCA—migraine	1.04e-05	0.00121	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR7—migraine	9.77e-06	0.00113	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LRP1—migraine	9.57e-06	0.00111	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CACNA1A—migraine	8.65e-06	0.001	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOTCH4—migraine	7.35e-06	0.000853	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CACNA1A—migraine	7.33e-06	0.000851	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR1B—migraine	7.09e-06	0.000823	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR1A—migraine	6.82e-06	0.000792	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TAC1—migraine	6.72e-06	0.00078	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PGR—migraine	6.72e-06	0.00078	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NPS—migraine	6.72e-06	0.00078	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR2C—migraine	6.59e-06	0.000765	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDNRA—migraine	6.41e-06	0.000744	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOTCH3—migraine	6.25e-06	0.000725	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CALCA—migraine	6.17e-06	0.000716	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR7—migraine	5.77e-06	0.00067	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CACNA1A—migraine	5.66e-06	0.000657	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TGFBR2—migraine	4.97e-06	0.000577	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ESR1—migraine	3.59e-06	0.000417	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—migraine	2.86e-06	0.000332	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—migraine	2.42e-06	0.000282	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—migraine	1.87e-06	0.000217	CbGpPWpGaD
